BRANFORD, Conn., June 8, 2009 (GLOBE NEWSWIRE) -- CAS Medical Systems, Inc. (Nasdaq:CASM) today announced that five studies were presented at Euroanaesthesia 2009, the annual meeting of the European Society of Anaesthesia, on June 6-8, 2009 in Milan, Italy, demonstrating utility of the FORE-SIGHT(r) Absolute Cerebral Oximetry technology in monitoring during surgery and critical care. These studies were all conducted by Cathy S. DeDeyne, MD and her colleagues at the Department of Anaesthesia & Neurosurgery, Ziekenhuis Oost-Limburg, Genk, Belgium.
Data from these early studies demonstrate that cerebral tissue oxygen saturation (SctO2) provided clinicians with new information that can be used to manage patients in neuro-critical care. Applications include cerebral aneurysm surgery, craniotomy following acute intracerebral bleeding, endoscopic shoulder surgery, hyperthermic intraperitoneal chemotherapy (HIPEC), and carotid endarterectomy.
In addition, three abstracts demonstrating the clinical utility of FORE-SIGHT were also recently presented at 2009 OUTCOMES on May 29, 2009 in Barbados. These studies demonstrated a link between the use of absolute cerebral oximetry during aortic surgery and length of stay; clinical utility of cerebral oximetry in detecting desaturation events associated with patients receiving anesthetics in the beach chair position for shoulder surgery; and the link between patient positional changes to total hemoglobin and cerebral tissue saturation. These studies were all conducted at Mt. Sinai Medical Center in New York City.
Andrew Kersey, President and CEO, stated, "These studies further advance the awareness and use of our FORE-SIGHT Absolute Cerebral Oximetry technology and the importance of this measurement parameter to improving patient care. We are pleased with the increased exposure the presentation of these studies give us with key thought leaders in the U.S. and in Europe."
References
(1) I. Bertrand, C. DeDeyne, J. Wuyts, F. Jans, R. Heylen. Monitoring of Brain Oxygenation During Complex Cerebral Aneurysm Surgery by Absolute Cerebral Oxygen Saturation (FORE-SIGHT technology). Eur J Anaesthesiol 2009; 26 (Suppl 45): 7AP5-8.
(2) D. Dylst, C. DeDeyne, F. Weyns, F. Jans, R. Heylen. Monitoring of Absolute Cerebral Oxygen Saturation (FORE-SIGHT Technology) During Craniotomy for Acute Intracerebral Bleeding. Eur J Anaesthesiol 2009; 26 (Suppl 45): 7AP5-6.
(3) R. Somers, C. DeDeyne, F. Jans, J. Oosterbosch, R. Heylen. Monitoring of Absolute Cerebral Oxygen Saturation (FORE-SIGHT technology) During Endoscopic Shoulder Surgery: Benchchair Positioning Compared to Conventional Positioning. Eur J Anaesthesiol 2009; 26 (Suppl 45): 3AP6-11.
(4) E. DeTroy, C. DeDeyne, K. Vanderspeeten, F. Jans, R. Heylen. Monitoring of Brain Oxygenation During Hyperthermic Intraperitoneal Chemotherapy (HIPEC) Procedures. Eur J Anaesthesiol 2009; 26 (Suppl 45): 3AP6-10.
(5) S. Lamote, C. DeDeyne, W. Lansink, F. Jans, R. Heylen. Non-Invasive Monitoring of Absolute Cerebral Oxygen Saturation (FORE-SIGHT, CASMED) During Elective Shunting Procedure for Carotid Enarterectomy. Eur J Anaesthesiol 2009; 26 (Suppl 45): 3AP6-9.
(6) M. Weiner, G.W. Fischer et. al. Cerebral Oximetry Monitoring in Patients Undergoing Surgery with Regional Anesthesia in the Beach Chair Position. Outcomes 2009.
(7) A. Afonso, G.W. Fischer et. al. Decreasted Cerebral Tissue Oxygen Saturation during Aortic Surgery Increases Length of Stay. Outcomes 2009.
(8) A. Afonso, G.W. Fischer et. al. Influence of Positional Changes on SctO2 and CBV. Outcomes 2009.
Further information about FORE-SIGHT and these clinical studies can be found at: www.cerebraloximetry.com.
About CASMED(r) - Monitoring What's Vital
CAS Medical Systems, Inc. is a leading developer and manufacturer of medical devices for non-invasive patient monitoring. The Company's FORE-SIGHT Absolute Cerebral Oximeter is the first cerebral oximeter available with FDA clearance for non-invasive, continuous measurement of absolute cerebral tissue oxygen saturation for neonates, infants, children and adults. This information helps avert brain damage or death during surgery and in critical care situations by allowing clinicians to identify patients with dangerously low levels of cerebral oxygen and intervene to reverse the condition.
The Company's product lines include the high-acuity monitoring capabilities of the FORE-SIGHT Cerebral Oximeter; the bedside patient monitoring line of vital signs and cardio-respiratory monitoring products, proprietary non-invasive blood pressure measurement technology, and supplies and service including blood pressure cuffs and products for neonatal intensive care. CASMED products are designed to meet the needs of a full spectrum of patient populations worldwide, ranging from adults to pediatrics and neonates.
The CAS Medical Systems, Inc. logo is available at http://www.globenewswire.com/newsroom/prs/?pkgid=4675
For further information regarding CAS Medical Systems, Inc., visit the Company's website at www.casmed.com.
Statements included in this press release, which are not historical in nature, are forward-looking statements made pursuant to the safe harbor provisions of the Private Securities Litigation Reform Act of 1995. Statements relating to the future financial performance of the Company are subject to many factors including, but not limited to, the customer acceptance of the products in the market, the introduction of competitive products and product development, commercialization and technological difficulties, the impact of actions and events involving key customers and vendors, and other risks detailed in the Company's Form 10-K for the year ended December 31, 2008 and other subsequent Securities and Exchange Commission filings.
Such statements are based upon the current beliefs and expectations of the Company's management and are subject to significant risks and uncertainties. Actual results may differ from those set forth in the forward-looking statements. When used in this press release the terms "anticipate", "believe", "estimate", "expect", "may", "objective", "plan", "possible", "potential", "project", "will" and similar expressions identify forward-looking statements. The forward-looking statements contained in this press release are made as of the date hereof, and we do not undertake any obligation to update any forward-looking statements, whether as a result of future events, new information or otherwise.